Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and.
Duke Proteomics and Metabolomics Shared Resource, Duke University Medical Center, Durham, North Carolina, USA.
JCI Insight. 2020 Jan 16;5(1):131232. doi: 10.1172/jci.insight.131232.
The T helper 2 (Th2) inflammatory cytokine interleukin-13 (IL-13) has been associated with both obstructive and fibrotic lung diseases; however, its specific effect on the epithelial stem cells in the gas exchange compartment of the lung (alveolar space) has not been explored. Here, we used in vivo lung models of homeostasis and repair, ex vivo organoid platforms, and potentially novel quantitative proteomic techniques to show that IL-13 disrupts the self-renewal and differentiation of both murine and human type 2 alveolar epithelial cells (AEC2s). Significantly, we find that IL-13 promotes ectopic expression of markers typically associated with bronchiolar airway cells and commonly seen in the alveolar region of lung tissue from patients with idiopathic pulmonary fibrosis. Furthermore, we identify a number of proteins that are differentially secreted by AEC2s in response to IL-13 and may provide biomarkers to identify subsets of patients with pulmonary disease driven by "Th2-high" biology.
辅助性 T 细胞 2(Th2)炎症细胞因子白细胞介素-13(IL-13)与阻塞性和纤维性肺疾病都有关;然而,其对肺气体交换区(肺泡)上皮干细胞的确切作用尚未得到探索。在这里,我们使用体内平衡和修复的肺模型、体外类器官平台以及潜在的新型定量蛋白质组学技术,表明 IL-13 破坏了鼠和人 2 型肺泡上皮细胞(AEC2)的自我更新和分化。重要的是,我们发现 IL-13 促进了通常与细支气管气道细胞相关的标志物的异位表达,这些标志物在特发性肺纤维化患者的肺组织肺泡区域中也很常见。此外,我们鉴定出许多由 AEC2 响应 IL-13 而差异分泌的蛋白质,这些蛋白质可能提供生物标志物,以鉴定由“Th2 高”生物学驱动的肺病患者亚群。